相似文献
1
DNA Vaccine Development at Pre- and Post-Operation Warp Speed.
Vaccines (Basel). 2020 Dec 4;8(4):737. doi: 10.3390/vaccines8040737.
2
Developing a SARS-CoV-2 Vaccine at Warp Speed.
JAMA. 2020 Aug 4;324(5):437-438. doi: 10.1001/jama.2020.12190.
3
A race for a better understanding of COVID-19 vaccine non-adopters.
Brain Behav Immun Health. 2020 Dec;9:100159. doi: 10.1016/j.bbih.2020.100159. Epub 2020 Oct 9.
4
Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.
Adv Drug Deliv Rev. 2014 Jul;74:28-34. doi: 10.1016/j.addr.2014.05.011. Epub 2014 May 23.
5
Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives.
Virology. 2006;356(1-2):115-25. doi: 10.1016/j.virol.2006.07.038. Epub 2006 Aug 28.
6
Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.
J Virol. 2019 Aug 13;93(17). doi: 10.1128/JVI.00720-19. Print 2019 Sep 1.
7
Breeding Strategy Determines Rupture Incidence in Post-Infarct Healing WARPing Cardiovascular Research.
PLoS One. 2015 Sep 25;10(9):e0139199. doi: 10.1371/journal.pone.0139199. eCollection 2015.
8
A novel "in-feed" delivery platform applied for oral DNA vaccination against IPNV enables high protection in Atlantic salmon (Salmon salar).
Vaccine. 2017 Jan 23;35(4):626-632. doi: 10.1016/j.vaccine.2016.12.013. Epub 2016 Dec 21.
9
Evaluation of the WARP-turbo spin echo sequence for 3 Tesla magnetic resonance imaging of stifle joints in dogs with stainless steel tibial plateau leveling osteotomy implants.
Vet Radiol Ultrasound. 2014 Jul-Aug;55(4):414-9. doi: 10.1111/vru.12141. Epub 2014 Jan 20.
10
Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates.
Vaccine. 2016 Jun 24;34(30):3500-7. doi: 10.1016/j.vaccine.2016.03.108. Epub 2016 Apr 13.
引用本文的文献
1
Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern.
Viruses. 2023 Feb 24;15(3):624. doi: 10.3390/v15030624.
本文引用的文献
1
Genetically Modified Mouse Mesenchymal Stem Cells Expressing Non-Structural Proteins of Hepatitis C Virus Induce Effective Immune Response.
Vaccines (Basel). 2020 Feb 2;8(1):62. doi: 10.3390/vaccines8010062.
2
The Increase of the Magnitude of Spontaneous Viral Blips in Some Participants of Phase II Clinical Trial of Therapeutic Optimized HIV DNA Vaccine Candidate.
Vaccines (Basel). 2019 Aug 20;7(3):92. doi: 10.3390/vaccines7030092.
3
Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice.
Vaccines (Basel). 2019 Aug 2;7(3):78. doi: 10.3390/vaccines7030078.
4
Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice.
Vaccines (Basel). 2019 Jul 16;7(3):64. doi: 10.3390/vaccines7030064.
5
Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation.
Vaccines (Basel). 2019 Jun 13;7(2):50. doi: 10.3390/vaccines7020050.
6
Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein-Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth.
Vaccines (Basel). 2019 May 24;7(2):44. doi: 10.3390/vaccines7020044.
7
Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model.
Vaccines (Basel). 2019 May 22;7(2):42. doi: 10.3390/vaccines7020042.
8
Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines.
Vaccines (Basel). 2019 Apr 30;7(2):38. doi: 10.3390/vaccines7020038.
9
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies.
Vaccines (Basel). 2019 Apr 24;7(2):37. doi: 10.3390/vaccines7020037.
10
In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice.
Vaccines (Basel). 2019 Mar 29;7(2):34. doi: 10.3390/vaccines7020034.
Zotero 插件